BENGALURU: India’s government said on Tuesday it has approved Gilead Sciences Inc’s antiviral drug remdesivir for emergency use in treating COVID-19 patients.
Remdesivir is the first drug to show improvement in COVID-19 patients in formal clinical trials.
It was granted emergency use authorisation by the U.S. Food and Drug Administration last month and has received approval by Japanese health regulators.
“(Remdesivir) approved on June 1 under emergency use with condition for five dose administration”, the Drugs Controller General of India said in an email statement.
The drugmaker did not immediately respond to an email seeking further details.
Read More: US Marines undergo quarantine after landing in northern Australian city
(With Input from INP)
